Jon R. Levine

Jon R. Levine appears in our data through filings on Marimed Inc. shares, published by SEC (Form 4). Between 7 September 2025 and 15 October 2026, the trades on record add up to 25 filings.

Purchases make up the whole of the open-market record (3 purchases, €2,808). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 13 option exercises. In 2026 alone, the filings show 3 purchases and no sales.

In size, the median ticket on the buying side is €931. Relative to company size, the median is 0.0039% of market cap (3 purchases with a known value). The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.

Most recently, on 19 October 2026, the filings show a transaction worth €339 in Marimed Inc. The last purchase on record was published on 26 May 2026, which is 147 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.